Nothing Special   »   [go: up one dir, main page]

OA09301A - "New oral dosage form improving bioavailability". - Google Patents

"New oral dosage form improving bioavailability".

Info

Publication number
OA09301A
OA09301A OA59830A OA59830A OA09301A OA 09301 A OA09301 A OA 09301A OA 59830 A OA59830 A OA 59830A OA 59830 A OA59830 A OA 59830A OA 09301 A OA09301 A OA 09301A
Authority
OA
OAPI
Prior art keywords
dosage form
oral dosage
new oral
improving bioavailability
form improving
Prior art date
Application number
OA59830A
Other languages
French (fr)
Inventor
Besancon Denis
Pr Alache Jean-Marc
Dufour Alain
Ecros Fabrice
Original Assignee
Delagrange Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delagrange Lab filed Critical Delagrange Lab
Publication of OA09301A publication Critical patent/OA09301A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2063Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA59830A 1989-08-07 1990-08-06 "New oral dosage form improving bioavailability". OA09301A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8910605A FR2650502B1 (en) 1989-08-07 1989-08-07 NEW ORAL GALENIC FORM IMPROVING BIOAVAILABILITY

Publications (1)

Publication Number Publication Date
OA09301A true OA09301A (en) 1992-09-15

Family

ID=9384532

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59830A OA09301A (en) 1989-08-07 1990-08-06 "New oral dosage form improving bioavailability".

Country Status (25)

Country Link
EP (1) EP0412877A1 (en)
JP (1) JPH0377819A (en)
KR (1) KR910004181A (en)
CN (1) CN1049455A (en)
AU (1) AU631235B2 (en)
CA (1) CA2022447A1 (en)
CS (1) CS383890A3 (en)
DD (1) DD297332A5 (en)
DE (1) DE4023136A1 (en)
FI (1) FI903885A0 (en)
FR (1) FR2650502B1 (en)
GB (1) GB2234898A (en)
HU (1) HU204997B (en)
IE (1) IE902629A1 (en)
IL (1) IL95105A0 (en)
IN (1) IN170789B (en)
LU (1) LU87777A1 (en)
MA (1) MA21923A1 (en)
NO (1) NO903442L (en)
NZ (1) NZ234593A (en)
OA (1) OA09301A (en)
PE (1) PE491A1 (en)
PT (1) PT94823A (en)
TN (1) TNSN90111A1 (en)
ZA (1) ZA905886B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2133633T3 (en) * 1992-01-17 1999-09-16 Alfatec Pharma Gmbh PROCEDURE FOR THE PRODUCTION OF POWDERS, GRANULATES OR PELETS CONTAINING AN ACTIVE SUBSTANCE, WITH A STRUCTURE BASED ON HYDROPHILIC MACROMOLECULES, AND THEIR USE.
DE4221880A1 (en) * 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Solid and liquid solutions of poorly water-soluble drugs
KR20030089147A (en) * 2002-05-16 2003-11-21 슈라펫 주식회사 Water bottle for pet

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE854414C (en) * 1949-04-26 1952-11-04 Dieter Dr Med Ellenbeck Process for the production of injectable solutions of more or less poorly soluble medicaments
GB715874A (en) * 1952-10-03 1954-09-22 Horlicks Ltd A tablet for use in treating peptic ulcers
GB906422A (en) * 1958-05-02 1962-09-19 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical preparations
US3015611A (en) * 1959-08-25 1962-01-02 Nysco Lab Inc Low density whey-bound tablets
GB1063872A (en) * 1962-08-11 1967-03-30 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical compositions
US3594467A (en) * 1968-10-09 1971-07-20 Richardson Merrell Inc Long-lasting troche
US3922379A (en) * 1973-12-17 1975-11-25 Abbott Lab Microencapsulation process
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
DE3250023T (en) * 1981-01-14 1990-03-29
FR2524312B1 (en) * 1982-04-01 1985-10-04 Tech Cuir Centre NOVEL FORMS OF MICRO-ENCAPSULATION OF DRUG SUBSTANCES BY HOMOGENEOUS LAYERS OF NATIVE COLLAGEN
JPS59101423A (en) * 1982-12-02 1984-06-12 Takada Seiyaku Kk Novel solid pharmaceutical preparation of nifedipine
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
US4670251A (en) * 1984-05-30 1987-06-02 Igene Biotechnology, Inc. Microcrystalline tableting excipient derived from whey
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
IL78017A (en) * 1986-03-03 1989-06-30 Yissum Res Dev Co Sustained release tablets of theophylline
DE3702105A1 (en) * 1987-01-24 1988-08-04 Bayer Ag PARENTERAL SOLUTION
US5051406A (en) * 1987-03-04 1991-09-24 Nippon Hypox Laboratories Incorporated Pharmaceutical composition using albumin as a carrier and process for producing the same
CA1324083C (en) * 1987-03-09 1993-11-09 Tetsu Miyoshi Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
DK179687D0 (en) * 1987-04-08 1987-04-08 Farma Food As PREPARATION
ATE90205T1 (en) * 1987-09-08 1993-06-15 Takeda Chemical Industries Ltd WATER-INSOLUBLE CYTOKINS.

Also Published As

Publication number Publication date
DE4023136A1 (en) 1991-02-14
IE902629A1 (en) 1991-02-27
LU87777A1 (en) 1990-12-11
HU904909D0 (en) 1991-01-28
TNSN90111A1 (en) 1991-03-05
PT94823A (en) 1991-04-18
HUT55230A (en) 1991-05-28
EP0412877A1 (en) 1991-02-13
GB2234898A (en) 1991-02-20
GB9017144D0 (en) 1990-09-19
KR910004181A (en) 1991-03-28
AU6023990A (en) 1991-02-07
NZ234593A (en) 1993-04-28
FR2650502B1 (en) 1994-05-27
IN170789B (en) 1992-05-23
CN1049455A (en) 1991-02-27
CS276556B6 (en) 1992-06-17
DD297332A5 (en) 1992-01-09
FI903885A0 (en) 1990-08-06
IL95105A0 (en) 1991-06-10
JPH0377819A (en) 1991-04-03
AU631235B2 (en) 1992-11-19
CS383890A3 (en) 1992-06-17
CA2022447A1 (en) 1991-02-08
FR2650502A1 (en) 1991-02-08
MA21923A1 (en) 1991-04-01
ZA905886B (en) 1991-04-24
HU204997B (en) 1992-03-30
NO903442L (en) 1991-02-08
PE491A1 (en) 1991-01-26
NO903442D0 (en) 1990-08-06

Similar Documents

Publication Publication Date Title
FI901102A0 (en) PHARMACEUTICAL COMPOSITION.
ITRM910696A0 (en) PHARMACEUTICAL COMPOSITIONS FOR NASAL APPLICATION.
ITBO910024A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY.
DE69009315D1 (en) Cinnamamide derivatives.
MA22668A1 (en) PROCESS FOR THE PREPARATION OF OXAMIDES.
IT8920486A0 (en) PHARMACEUTICAL COMPOSITIONS.
IT8948696A0 (en) ORAL COMPOSITION ANTIBACTERIAL, ANTIPLQUE, ANTITARTAR
DE3775802D1 (en) 2- (4'-ALKOXYPHENYL) -5-ALKYLPYRIDINE.
IT8767057A0 (en) LONG-RELEASE PHARMACEUTICAL COMPOSITIONS, RELATIVE DOSAGE FORMS AND PROCEDURE FOR THEIR PREPARATION
IT8919074A0 (en) COMPOSITION FOR ORAL HYGIENE.
DE59010722D1 (en) 2,4-dimethyl-6-s-alkylphenols
ITMI913465A1 (en) PROCEDURE FOR THE PURIFICATION OF 1, 1, 1-TRIFLUORO-2-FLUOROETANO
IT9047924A0 (en) COMPOSITION FOR ORAL HYGIENE.
ITMI910284A1 (en) PROCESS FOR THE PREPARATION OF 2, 2, 6, 6-TETRAMETHY-4-PIPERIDILAMINS
DK360888D0 (en) 3 ', 4'-DINITROGEN SUBSTITUTED EPIPODOPHYLLOTOXING LUCOSIDE DERIVATIVES
IT8920405A0 (en) PHARMACOLOGICALLY ACTIVE AMINOIMIDAZOPYRIDINES.
DK10190D0 (en) 1,1-DIOXO-CEPHEM-4-CARBOTHIOLIC ACID DERIVATIVES
ITMI910320A1 (en) PROCESS FOR THE PREPARATION OF 1. 3-DIOXINS
DE69122555D1 (en) 2,4-Dihydroxyadipic acid derivatives
OA09301A (en) "New oral dosage form improving bioavailability".
IT1236969B (en) 3-CYAN-3,5,5'-TRIMETHYL-1-CYCLOHEXANONE PREPARATION PROCEDURE.
DE69002865D1 (en) Oral preparation.
IT1215261B (en) PHARMACEUTICAL COMPOSITIONS ANTIGALACTOPOIETIC ADAPTITY.
IT8621925A0 (en) PHARMACEUTICAL COMPOSITIONS ANTINEOPLASTIC ADAPTIVITY.
LT2623B (en) CHANGED 1,3,4,9-TETRAHIDROPIRAN (3,4-BETA) INDOL-1-ACTO RUGSCIU OR ITS PHARMACEUTICAL ACCEPTABLE SALTS